Xtant Medical
-
Biologics
Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors
BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance
Initiates Annual Revenue Guidance of $73 Million – $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE…
Read More » -
Financial
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
BELGRADE, Mont., March 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Spine
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital…
Read More » -
Spine
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
BELGRADE, Mont., Jan. 09, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Third Quarter 2022 Financial Results
BELGRADE, Mont., Nov. 03, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment
BELGRADE, Mont., Oct. 11, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment
BELGRADE, Mont., Aug. 31, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces $9.75 Million Private Investment
Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont., Aug. 24, 2022 (GLOBE NEWSWIRE) — Xtant…
Read More » -
Financial
Xtant Medical Announces Second Quarter 2022 Financial Results
BELGRADE, Mont., Aug. 05, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces First Quarter 2022 Financial Results
BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Appoints Scott Neils as Chief Financial Officer
BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results
BELGRADE, Mont., March 08, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Spine
Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference
BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Third Quarter 2021 Financial Results
BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More »